Although Europe identified the pathway to tuberculosis (TB) elimination in 1990, no information on programmes for country preparedness is available. A questionnaire investigating TB elimination activities was submitted to 38 national TB programme representatives of low TB incidence (<20 cases per 100 000 population) European countries/territories of the World Health Organization European region. Out of 31 providing a complete answer, 17 (54.8%) reported to have a dedicated national TB programme, 20 (64.5%) a national plan including TB elimination (13 (41.9%) including targets), 22 (71%) guidelines, 14 (45.2%) a specific budget for TB activities, and 23 (74.2%) TB reference centres. All countries reported having case-based electronic TB surveillance, 19 (61.3%) perform regular supervision, 12 (38.7%) have a monitoring and evaluation plan and five (16.1%) perform modelling. In three countries (9.7%), TB health services are free for insured individuals only. In 22 countries/territories (71%) not all TB drugs were available, while in 12 (38.7%) drug stock-outs have been described. Although high-risk group screening for latent TB infection is performed by the majority of countries, only 6 (19.4%) provided figures on preventive treatment completion rates. Not all elements identified as essential for country preparedness to achieve TB elimination are available in the countries surveyed.

Tuberculosis elimination: theory and practice in Europe

SPANEVELLO, ANTONIO;
2014-01-01

Abstract

Although Europe identified the pathway to tuberculosis (TB) elimination in 1990, no information on programmes for country preparedness is available. A questionnaire investigating TB elimination activities was submitted to 38 national TB programme representatives of low TB incidence (<20 cases per 100 000 population) European countries/territories of the World Health Organization European region. Out of 31 providing a complete answer, 17 (54.8%) reported to have a dedicated national TB programme, 20 (64.5%) a national plan including TB elimination (13 (41.9%) including targets), 22 (71%) guidelines, 14 (45.2%) a specific budget for TB activities, and 23 (74.2%) TB reference centres. All countries reported having case-based electronic TB surveillance, 19 (61.3%) perform regular supervision, 12 (38.7%) have a monitoring and evaluation plan and five (16.1%) perform modelling. In three countries (9.7%), TB health services are free for insured individuals only. In 22 countries/territories (71%) not all TB drugs were available, while in 12 (38.7%) drug stock-outs have been described. Although high-risk group screening for latent TB infection is performed by the majority of countries, only 6 (19.4%) provided figures on preventive treatment completion rates. Not all elements identified as essential for country preparedness to achieve TB elimination are available in the countries surveyed.
2014
http://erj.ersjournals.com/content/43/5/1410.full.pdf
Tuberculosis; tuberculosis control; tuberculosis eradication
D'Ambrosio, L.; Dara, M.; Tadolini, M.; Centis, R.; Sotgiu, G.; Van Der Werf, M. J.; Gaga, M.; Cirillo, D.; Spanevello, Antonio; Raviglione, M.; Blasi, F.; Migliori, G. B.; Hafizi, H.; Wanlin, M.; Oñate, W. A.; Groenen, G.; Janković, V. K.; Šimunović, A.; Wallenfels, J.; Voniatis, C.; Andersen, P. H.; Viiklepp, P.; Danilovits, M.; Kummik, T.; Ruutu, P.; Comolet, T. M.; Haas, W.; Korr, G.; Rüsch Gerdes, S.; Bauer, T.; Hauer, B.; Brodhun, B.; Papavenstsis, K.; Papadima, S.; Pusztai, Z.; O'Donnell, J.; Chemtob, D.; Girardi, E.; Mehmeti, R.; Riekstina, V.; Asciak, A. P.; Arnesen, T. M.; Augustynowicz Kopeć, E.; Korzeniewska Kosela, M.; Miskiewicz, P. M.; Miecznikowska, D.; Duarte, R.; Correia, A. M.; Diniz, A. M. S. C.; Talevski, S.; Zakoska, M.; Popescu, G.; Chiotan, D.; Asic, . R. J.; Solovic, I.; Ivanuša, M.; Košnik, M.; Valín, E. R.; Anchuela, O. T.; Jonsson, J.; Helbling, P.; Zellweger, J. P.; De Vries, G.; Erkens, C.; Anderson, L.; Laurenson, I.; European National Programme, Representatives
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1911520
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 138
  • ???jsp.display-item.citation.isi??? 126
social impact